Company secures a visionary health affairs leader for the launch of their innovative Parkinson’s diagnosis software.
GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that David R. Nelson, MD has accepted to serve on neuropacs’ Board of Advisors, effective immediately.
Dr. Nelson is the former Senior Vice President for Health Affairs at the University of Florida and President of UF Health, during which he oversaw operations for all components of UF Health, the university’s academic health center, with campuses in Gainesville and Jacksonville. This included six health science colleges, nine interdisciplinary research centers, three hospital systems and more than 100 physician practices. A professor of medicine and an expert in liver disease, Dr. Nelson’s record of academic achievement includes more than $100 million in research funding, more than 200 publications and multiple leadership roles in his area of expertise. He has continuously been recognized as one of America’s top physicians/gastroenterologists and has been the recipient of multiple exemplary teaching awards, an Outstanding Alumnus Award from his medical school, a UF Research Foundation Professorship Award and a UF Term Professorship Award. Dr. Nelson received his undergraduate degree from Dartmouth College and his medical degree from State University of New York Upstate University in Syracuse, New York. He completed a residency in internal medicine at the University of Massachusetts and obtained fellowship training in gastroenterology and hepatology at UF.
“Dr Nelson is a pivotal addition to our team of advisors. His expertise will be key to commercializing neuropacsTM, our innovative AI-driven platform for the diagnosis of various forms of Parkinsonism, which is expected to be launched in 3Q25”, commented Dr. Martin Handfield, neuropacs’ President and CEO. He added “ as a physician, scientist and hospital administrator, Dr. Nelson is perfectly aligned with neuropacs’ mission to translate physiological principles underpinning neurological disorders into real-world diagnostics and therapies to improve a patient’s life and wellbeing.”
“I’m thrilled with the opportunity to contribute to neuropacs’ mission, and I believe that neuropacs’ innovative diagnostic tool has the potential to change how several neurodegenerative diseases will soon be diagnosed, ultimately enabling earlier intervention and improved patient outcomes”, commented Dr. Nelson. He added ”I believe that clinicians should strive on going “where the puck is going” clinically and integrate AI-assisted tools where appropriate, and as innovative tools are being developed, validated and brought to the clinic.”
For more information about neuropacsTM and its revolutionary diagnostic solutions, visit neuropacs.com.
About neuropacsTM:
neuropacsTM is a pioneering neurological technology company dedicated to developing innovative AI-driven diagnostics. With a commitment to advancing healthcare through cutting-edge technologies, neuropacsTM remains at the forefront of revolutionizing clinical care standards.
Forward-Looking Statements
This communication includes express and implied “forward-looking statements.” Forward-looking statements include all statements that are not historical facts and in some cases, can be identified by terms such as “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “objective,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “ongoing,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. By their nature, these statements are subject to numerous risks and uncertainties, that could cause actual results, performance or achievement to differ materially and adversely from those anticipated or implied in the statements. You should not rely upon forward-looking statements as predictions of future events. Although our management believes that the expectations reflected in our statements are reasonable, we cannot guarantee that the future results, performance, or events and circumstances described in the forward-looking statements will be achieved or occur. Recipients are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date such statements are made and should not be construed as statements of fact. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, any future presentations, or otherwise, except as required by applicable law.